Fundraising FoxAlba Equity
Angel networkAberdeen · Seed–Series A
Find your way into Alba Equity
Sign up to see every warm intro you have to Alba Equity
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alba Equity team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Alba Equity operates as an investment syndicate whose members provide both capital and hands-on support to high-growth businesses. It seeks ambitious founders and management teams that can show a clear equity growth opportunity, a well-defined route to market, potential future exit options and high-quality information. Most opportunities the syndicate progresses qualify under the UK's EIS and/or SEIS tax-relief schemes. Members retain full discretion over which deals they participate in, and the firm draws on relationships with many organisations and individuals as a regular source of potential investment opportunities.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 3 of 11 portfolio companiesBiotech ×3Healthtech ×3Medical Devices ×3AI & Machine Learning ×2Deep Tech ×1Longevity ×1
HQs:United Kingdom×2
Investments · 11 tracked
founders shown can be your intro pathCarcinotech produces bioprinted tumor models combining patient-derived biological material with automated workflows to generate reproducible tumor tissue systems for drug discovery and testing.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesEdinburgh, GB
Lorna(Chief Scientific Officer)
Co-investorsTRICAPITALBritish Business BankEos AdvisoryGabriel Investment SyndicateInvesting Women AngelsInvestment Fund for Scotland+4 more
Cumulus Oncology is a drug development company specializing in oncology therapeutics, leveraging experienced leadership with track records in new drug applications and successful M&A transactions.
BiotechHealthtechLongevityMedical Devices
Catherine(CEO)Clare Wareing(CEO)in
Co-investorsApollo Informal InvestmentEos AdvisoryScottish National Investment BankScottish Enterprise
Dxcover provides a platform for rapid development of liquid biopsies to detect cancer and other diseases.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsEos AdvisoryScottish EnterpriseBritish Business BankMaven Capital Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CumulusGM FlowITZA MediaLeap AutomationPneumowaveSentinel Subsea LimitedTrojanTrojanenergyltd
Frequently asked questions
- How many investments has Alba Equity made?
- Alba Equity has 11 tracked investments.
- What stage does Alba Equity invest at?
- Alba Equity invests at the Seed, Series A stages.
- What sectors does Alba Equity focus on?
- Alba Equity focuses on EdTech, Medical Devices, Sector Agnostic.
- Where is Alba Equity located?
- Alba Equity is headquartered in Aberdeen, GB.
- Does Alba Equity lead rounds?
- Yes, Alba Equity leads investment rounds.
- Who does Alba Equity co-invest with?
- Alba Equity most often shares deals with Eos Advisory, Scottish National Investment Bank, Apollo Informal Investment, among 5 tracked co-investors.
Similar investors
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
OMERS Ventures is a venture capital firm that invests in founders globally, with investment teams based in New York, Palo Alto, and Toronto.
Monolith Management is a 2021-founded AI-focused venture capital fund in China that operates both early-stage venture funds and public-equity hedge funds under one roof, with founding partners from HongShan and Boyu Capital bringing combined growth PE and hedge fund experience. The firm raised $488m across dual-currency vehicles in 2025 despite challenging fundraising conditions for China USD venture, focusing exclusively on AI and frontier technologies across the full stack from applications to hardware and embodied intelligence.